Westfield Capital Management CO LP Rocket Pharmaceuticals, Inc. Transaction History
Westfield Capital Management CO LP
- $19.3 Billion
- Q1 2025
A detailed history of Westfield Capital Management CO LP transactions in Rocket Pharmaceuticals, Inc. stock. As of the latest transaction made, Westfield Capital Management CO LP holds 4,820,701 shares of RCKT stock, worth $14 Million. This represents 0.17% of its overall portfolio holdings.
Number of Shares
4,820,701
Previous 4,714,610
2.25%
Holding current value
$14 Million
Previous $59.3 Million
45.74%
% of portfolio
0.17%
Previous 0.27%
Shares
26 transactions
Others Institutions Holding RCKT
# of Institutions
220Shares Held
98.3MCall Options Held
611KPut Options Held
487K-
Rtw Investments, LP New York, NY17.7MShares$51.5 Million0.67% of portfolio
-
Lee Ainslie Maverick Capital LTD | Dallas, Tx8.36MShares$24.3 Million0.35% of portfolio
-
Black Rock Inc. New York, NY6.19MShares$18 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.12MShares$17.8 Million0.0% of portfolio
-
Suvretta Capital Management, LLC New York, NY4.14MShares$12.1 Million0.35% of portfolio
About ROCKET PHARMACEUTICALS, INC.
- Ticker RCKT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 75,683,696
- Market Cap $220M
- Description
- Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...